| Malignant astrocytic glioma: genetics, biology, and paths to treatment FB Furnari, T Fenton, RM Bachoo, A Mukasa, JM Stommel, A Stegh, ... Genes & development 21 (21), 2683-2710, 2007 | 2899 | 2007 |
| Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma BE Johnson, T Mazor, C Hong, M Barnes, K Aihara, CY McLean, ... Science 343 (6167), 189-193, 2014 | 1430 | 2014 |
| Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma R Bonavia, A Mukasa, Y Narita, DWY Sah, S Vandenberg, C Brennan, ... Genes & development 24 (16), 1731-1745, 2010 | 600 | 2010 |
| Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma PH Huang, A Mukasa, R Bonavia, RA Flynn, ZE Brewer, WK Cavenee, ... Proceedings of the National Academy of Sciences 104 (31), 12867-12872, 2007 | 477 | 2007 |
| A combination of TERT promoter mutation and MGMT methylation status predicts clinically relevant subgroups of newly diagnosed glioblastomas H Arita, K Yamasaki, Y Matsushita, T Nakamura, A Shimokawa, H Takami, ... Acta neuropathologica communications 4, 1-14, 2016 | 241 | 2016 |
| H3F3A K27M mutations in thalamic gliomas from young adult patients K Aihara, A Mukasa, K Gotoh, K Saito, G Nagae, S Tsuji, K Tatsuno, ... Neuro-oncology 16 (1), 140-146, 2014 | 189 | 2014 |
| Correlation of Histology and Molecular Genetic Analysis of 1p, 19q, 10q, TP53, EGFR, CDK4, and CDKN2A in 91 Astrocytic and Oligodendroglial Tumors K Ueki, R Nishikawa, Y Nakazato, T Hirose, J Hirato, N Funada, ... Clinical cancer research 8 (1), 196-201, 2002 | 189 | 2002 |
| Evolution of DNA repair defects during malignant progression of low-grade gliomas after temozolomide treatment HF van Thuijl, T Mazor, BE Johnson, SD Fouse, K Aihara, C Hong, ... Acta neuropathologica 129, 597-607, 2015 | 177 | 2015 |
| Genetic Variant RNF213 c.14576G>A in Various Phenotypes of Intracranial Major Artery Stenosis/Occlusion S Miyawaki, H Imai, M Shimizu, S Yagi, H Ono, A Mukasa, H Nakatomi, ... Stroke 44 (10), 2894-2897, 2013 | 168 | 2013 |
| Genomic characterization of primary central nervous system lymphoma K Fukumura, M Kawazu, S Kojima, T Ueno, E Sai, M Soda, H Ueda, ... Acta neuropathologica 131, 865-875, 2016 | 165 | 2016 |
| Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): a phase … T Kayama, S Sato, K Sakurada, J Mizusawa, R Nishikawa, Y Narita, ... Journal of Clinical Oncology 36 (33), 3282-3289, 2018 | 162 | 2018 |
| Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis/occlusion S Miyawaki, H Imai, S Takayanagi, A Mukasa, H Nakatomi, N Saito Stroke 43 (12), 3371-3374, 2012 | 150 | 2012 |
| 5-Hydroxymethylcytosine plays a critical role in glioblastomagenesis by recruiting the CHTOP-methylosome complex H Takai, K Masuda, T Sato, Y Sakaguchi, T Suzuki, T Suzuki, ... Cell reports 9 (1), 48-60, 2014 | 143 | 2014 |
| Genome-wide gene expression analysis for induced ischemic tolerance and delayed neuronal death following transient global ischemia in rats N Kawahara, Y Wang, A Mukasa, K Furuya, T Shimizu, T Hamakubo, ... Journal of Cerebral Blood Flow & Metabolism 24 (2), 212-233, 2004 | 142 | 2004 |
| Significance of IDH mutations varies with tumor histology, grade, and genetics in Japanese glioma patients A Mukasa, S Takayanagi, K Saito, J Shibahara, Y Tabei, K Furuya, T Ide, ... Cancer science 103 (3), 587-592, 2012 | 114 | 2012 |
| Diagnostic value of glutamate with 2-hydroxyglutarate in magnetic resonance spectroscopy for IDH1 mutant glioma H Nagashima, K Tanaka, T Sasayama, Y Irino, N Sato, Y Takeuchi, ... Neuro-oncology 18 (11), 1559-1568, 2016 | 109 | 2016 |
| Distinction in gene expression profiles of oligodendrogliomas with and without allelic loss of 1p A Mukasa, K Ueki, S Matsumoto, S Tsutsumi, R Nishikawa, T Fujimaki, ... Oncogene 21 (25), 3961-3968, 2002 | 99 | 2002 |
| Guanylate binding protein 1 is a novel effector of EGFR-driven invasion in glioblastoma M Li, A Mukasa, M del-Mar Inda, J Zhang, L Chin, W Cavenee, F Furnari Journal of Experimental Medicine 208 (13), 2657-2673, 2011 | 96 | 2011 |
| Oligodendrocyte progenitor cells and macrophages/microglia produce glioma stem cell niches at the tumor border T Hide, Y Komohara, Y Miyasato, H Nakamura, K Makino, M Takeya, ... EBioMedicine 30, 94-104, 2018 | 95 | 2018 |
| Mutually exclusive mutations of KIT and RAS are associated with KIT mRNA expression and chromosomal instability in primary intracranial pure germinomas S Fukushima, A Otsuka, T Suzuki, T Yanagisawa, K Mishima, A Mukasa, ... Acta neuropathologica 127, 911-925, 2014 | 93 | 2014 |
